NM_000535.7(PMS2):c.1408C>T (p.Pro470Ser) AND not specified - ClinVar (2024)

NM_000535.7(PMS2):c.1408C>T (p.Pro470Ser) AND not specified - ClinVar (1)

An official website of the United States government

NM_000535.7(PMS2):c.1408C>T (p.Pro470Ser) AND not specified - ClinVar (2)

The .gov means it's official.
Federal government websites often end in .gov or .mil. Beforesharing sensitive information, make sure you're on a federalgovernment site.

NM_000535.7(PMS2):c.1408C>T (p.Pro470Ser) AND not specified - ClinVar (3)

The site is secure.
The https:// ensures that you are connecting to theofficial website and that any information you provide is encryptedand transmitted securely.

Account

Logged in as:
username

  • Dashboard
  • Publications
  • Account settings
  • Log out

Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation

Relating variation to medicine

  • Advanced
  • Help
  • Home
  • About
    • Introduction
    • Data authorities
    • Names
    • Classification
    • Review status
    • HGVS expressions
    • Data validation
    • Submitters
    • Data dictionary
  • Access
    • Access and releases
    • Linking to ClinVar
  • Help
    • How to search ClinVar
    • Accessions and identifiers
    • Using the ClinVar variation display
    • Using the ClinVar record display
    • Comparing the variation and record displays
    • FAQ
  • Submit
    • Submission overview
    • Spreadsheets
    • Instructions for spreadsheets
    • Submission Portal
    • FAQ for submissions
    • Assertion criteria
    • Expert panels and practice guidelines
  • Statistics
    • Statistics
    • List of submitters
    • Submitting groups
  • FTP
    • Go to the FTP site
    • Overview

NM_000535.7(PMS2):c.1408C>T (p.Pro470Ser) AND not specified

Germline classification:
Benign (10 submissions)
Last evaluated:
Apr 16, 2018
Review status:
2 stars out of maximum of 4 stars

criteria provided, multiple submitters, no conflicts

Somatic classification
of clinical impact:
None
Review status:
(0/4)

no assertion criteria provided

Somatic classification
of oncogenicity:
None
Review status:
(0/4)

no assertion criteria provided

Record status:
current
Accession:
RCV000079103.42

Allele description [Variation Report for NM_000535.7(PMS2):c.1408C>T (p.Pro470Ser)]

NM_000535.7(PMS2):c.1408C>T (p.Pro470Ser)

Gene:
PMS2:PMS1 hom*olog 2, mismatch repair system component [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p22.1
Genomic location:
  • Chr7: 5987357 (on Assembly GRCh38)
  • Chr7: 6026988 (on Assembly GRCh37)
Preferred name:
NM_000535.7(PMS2):c.1408C>T (p.Pro470Ser)
HGVS:
  • NC_000007.14:g.5987357G>A
  • NG_008466.1:g.26750C>T
  • NM_000535.7:c.1408C>TMANE SELECT
  • NM_001322003.2:c.1003C>T
  • NM_001322004.2:c.1003C>T
  • NM_001322005.2:c.1003C>T
  • NM_001322006.2:c.1252C>T
  • NM_001322007.2:c.1090C>T
  • NM_001322008.2:c.1090C>T
  • NM_001322009.2:c.1003C>T
  • NM_001322010.2:c.847C>T
  • NM_001322011.2:c.475C>T
  • NM_001322012.2:c.475C>T
  • NM_001322013.2:c.835C>T
  • NM_001322014.2:c.1408C>T
  • NM_001322015.2:c.1099C>T
  • NP_000526.2:p.Pro470Ser
  • NP_001308932.1:p.Pro335Ser
  • NP_001308933.1:p.Pro335Ser
  • NP_001308934.1:p.Pro335Ser
  • NP_001308935.1:p.Pro418Ser
  • NP_001308936.1:p.Pro364Ser
  • NP_001308937.1:p.Pro364Ser
  • NP_001308938.1:p.Pro335Ser
  • NP_001308939.1:p.Pro283Ser
  • NP_001308940.1:p.Pro159Ser
  • NP_001308941.1:p.Pro159Ser
  • NP_001308942.1:p.Pro279Ser
  • NP_001308943.1:p.Pro470Ser
  • NP_001308944.1:p.Pro367Ser
  • LRG_161t1:c.1408C>T
  • LRG_161:g.26750C>T
  • LRG_161p1:p.Pro470Ser
  • NC_000007.13:g.6026988G>A
  • NM_000535.5:c.1408C>T
  • NM_000535.6:c.1408C>T
  • NP_000526.1:p.Pro470Ser
  • NR_136154.1:n.1495C>T
  • P54278:p.Pro470Ser
  • p.P470S
Protein change:
P159S
Links:
UniProtKB: P54278#VAR_016134; dbSNP: rs1805321
NCBI 1000 Genomes Browser:
rs1805321
Molecular consequence:
  • NM_000535.7:c.1408C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322003.2:c.1003C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322004.2:c.1003C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322005.2:c.1003C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322006.2:c.1252C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322007.2:c.1090C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322008.2:c.1090C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322009.2:c.1003C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322010.2:c.847C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322011.2:c.475C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322012.2:c.475C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322013.2:c.835C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322014.2:c.1408C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322015.2:c.1099C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_136154.1:n.1495C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
2

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

  • Clinical assertions
  • Evidence

Help

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000086042ITMI

no classification provided

not providedgermlinereference population

PubMed (1)
[See all records that cite this PMID]

SCV000110972Eurofins Ntd Llc (ga)

criteria provided, single submitter


(EGL ClinVar v180209 classification definitions)
Benign
(Apr 16, 2018)
germlineclinical testing

Citation Link,

SCV000304717PreventionGenetics, part of Exact Sciences

criteria provided, single submitter


(ACMG Guidelines, 2015)
Benigngermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000691974Mayo Clinic Laboratories, Mayo Clinic

no assertion criteria provided

Benignunknownclinical testing
SCV000711441Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine

criteria provided, single submitter


(LMM Criteria)
Benign
(Apr 20, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001744259Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen - VKGL Data-share Consensus

no assertion criteria provided

Benigngermlineclinical testing
SCV001906094Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided

Benigngermlineclinical testing
SCV001922389Clinical Genetics, Academic Medical Center - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided

Benigngermlineclinical testing
SCV001951485Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided

Benigngermlineclinical testing
SCV001971498Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided

Benigngermlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided22not providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknown101not providednot providednot providednot providedclinical testing
Africangermlineunknownnot providednot providednot provided43not providedreference population
African_Europeangermlineunknownnot providednot providednot provided46not providedreference population
Central_Asiangermlineunknownnot providednot providednot provided50not providedreference population
East_Asiangermlineunknownnot providednot providednot provided62not providedreference population
Europeangermlineunknownnot providednot providednot provided331not providedreference population
Hispanicgermlineunknownnot providednot providednot provided118not providedreference population
Whole_cohortgermlineunknownnot providednot providednot provided681not providedreference population

Citations

PubMed

Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.

Bodian DL, McCutcheon JN, Kothiyal P, Huddleston KC, Iyer RK, Vockley JG, Niederhuber JE.

PLoS One. 2014;9(4):e94554. doi: 10.1371/journal.pone.0094554.

PubMed [citation]

PMID:
24728327
PMCID:
PMC3984285

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:
25741868
PMCID:
PMC4544753

See all PubMed Citations (3)

Details of each submission

From ITMI, SCV000086042.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Africannot providednot providednot providedreference population PubMed (1)
2African_Europeannot providednot providednot providedreference population PubMed (1)
3Central_Asiannot providednot providednot providedreference population PubMed (1)
4East_Asiannot providednot providednot providedreference population PubMed (1)
5Europeannot providednot providednot providedreference population PubMed (1)
6Hispanicnot providednot providednot providedreference population PubMed (1)
7Whole_cohortnot providednot providednot providedreference population PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown43not provideddiscoverynot provided0.32469999999999999not providednot provided
2germlineunknown46not provideddiscoverynot provided0.378not providednot provided
3germlineunknown50not provideddiscoverynot provided0.29349999999999998not providednot provided
4germlineunknown62not provideddiscoverynot provided0.34510000000000002not providednot provided
5germlineunknown331not provideddiscoverynot provided0.40649999999999997not providednot provided
6germlineunknown118not provideddiscoverynot provided0.39219999999999999not providednot provided
7germlineunknown681not provideddiscoverynot provided0.3846not providednot provided

From Eurofins Ntd Llc (ga), SCV000110972.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided101not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided101not providednot providednot provided

From PreventionGenetics, part of Exact Sciences, SCV000304717.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Mayo Clinic Laboratories, Mayo Clinic, SCV000691974.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000711441.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testing PubMed (1)

Description

p.Pro470Ser in Exon 11 of PMS2: This variant is not expected to have clinical si gnificance because it has been identified in 45% (4560/10152) of Ashkenazi Jewis h chromosomes and 41% (52732/126656) of European chromosomes by the Genome Aggre gation Database (GnomAD, http://gnomad.broadinstitute.org; dbSNP rs1805321).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided2not provided2not provided

From Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen - VKGL Data-share Consensus, SCV001744259.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute - VKGL Data-share Consensus, SCV001906094.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Clinical Genetics, Academic Medical Center - VKGL Data-share Consensus, SCV001922389.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ - VKGL Data-share Consensus, SCV001951485.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center - VKGL Data-share Consensus, SCV001971498.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 7, 2024

Follow NCBI

NCBI Insights Blog

Connect with NLM

National Library of Medicine
8600 Rockville Pike
Bethesda, MD 20894

Help
Accessibility
Careers

NM_000535.7(PMS2):c.1408C>T (p.Pro470Ser) AND not specified - ClinVar (2024)
Top Articles
Latest Posts
Article information

Author: Terrell Hackett

Last Updated:

Views: 5579

Rating: 4.1 / 5 (72 voted)

Reviews: 95% of readers found this page helpful

Author information

Name: Terrell Hackett

Birthday: 1992-03-17

Address: Suite 453 459 Gibson Squares, East Adriane, AK 71925-5692

Phone: +21811810803470

Job: Chief Representative

Hobby: Board games, Rock climbing, Ghost hunting, Origami, Kabaddi, Mushroom hunting, Gaming

Introduction: My name is Terrell Hackett, I am a gleaming, brainy, courageous, helpful, healthy, cooperative, graceful person who loves writing and wants to share my knowledge and understanding with you.